Houston E Holmes III, MD - Texas Oncology PA

The US Oncology Network, supported by McKesson, is a national multi-specialty network dedicated to advancing community oncology practices by providing access to innovative clinical trials, extensive resources, and best business practices. With over 25 years of oncology practice management expertise, the Network treats approximately 1.4 million patients annually across 600 care sites, comprising 2,700 affiliated providers. By fostering independent practices and offering opportunities for participation in clinical trials, the US Oncology Network plays a crucial role in shaping the future of cancer treatment. Their commitment to patient-centric care and collaboration within the oncology community positions them as leaders in enhancing cancer care and ensuring practices can thrive amidst growing competition and regulatory demands. Generated from the website

Texas Oncology is a leading cancer treatment center in Dallas, TX, offering a comprehensive range of services and treatments for cancer and blood disorders. With a team of highly skilled physicians and advanced medical technologies, they provide personalized care and innovative treatment options, including chemotherapy, radiation therapy, precision medicine, and immunotherapy. As a part of The US Oncology Network, Texas Oncology is dedicated to providing exceptional patient care and advancing cancer research through clinical trials. They also offer a wide range of support services, including genetic risk evaluation, financial counseling, and patient support groups, to ensure a holistic approach to cancer treatment and patient well-being.Generated from the website

Dr. Carlos H. Becerra, based in Dallas, TX, is part of The US Oncology Network, which leverages over 25 years of oncology practice management expertise to enhance patient care and support independent cancer practices. With access to resources, best business practices, and the backing of McKesson, the network is dedicated to shaping the future of cancer treatment through innovative clinical trials and a patient-centric approach. The network comprises over 2,700 affiliated providers and treats approximately 1.4 million patients annually across 600 sites of care. By fostering relationships and providing comprehensive support, The US Oncology Network empowers local practices to thrive amidst the evolving landscape of healthcare while maintaining their independence. Generated from the website